At AACR, Scientists Detail Efforts to Combat Resistance to Targeted Cancer Drugs | GenomeWeb

WASHINGTON (GenomeWeb Daily News) — While cancer therapies targeted to the genetic makeup of patients' tumors have allowed for more precise treatment of disease, tumors bombarded with such drugs may develop resistance, even to such directed drugs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.